Richard D. Leff

2.7k total citations
86 papers, 2.0k citations indexed

About

Richard D. Leff is a scholar working on Pediatrics, Perinatology and Child Health, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Richard D. Leff has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pediatrics, Perinatology and Child Health, 19 papers in Biomedical Engineering and 13 papers in Molecular Biology. Recurrent topics in Richard D. Leff's work include Intravenous Infusion Technology and Safety (18 papers), Pharmaceutical studies and practices (13 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Richard D. Leff is often cited by papers focused on Intravenous Infusion Technology and Safety (18 papers), Pharmaceutical studies and practices (13 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Richard D. Leff collaborates with scholars based in United States, South Africa and Italy. Richard D. Leff's co-authors include Claudia Meek, Tawanda Gumbo, Shashikant Srivastava, Robert J. Roberts, Jotam G. Pasipanodya, Ronald G. Hall, Allen Erenberg, Devyani Deshpande, Carleton M. Sherman and Serkan Belkaya and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PEDIATRICS.

In The Last Decade

Richard D. Leff

84 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard D. Leff United States 25 828 722 326 309 293 86 2.0k
Christopher J. Destache United States 31 927 1.1× 535 0.7× 316 1.0× 180 0.6× 576 2.0× 128 3.2k
Joost Wauters Belgium 27 1.1k 1.3× 913 1.3× 309 0.9× 227 0.7× 215 0.7× 117 2.4k
Alison H. Thomson United Kingdom 27 334 0.4× 390 0.5× 831 2.5× 415 1.3× 392 1.3× 78 2.5k
B. Joseph Guglielmo United States 34 910 1.1× 883 1.2× 643 2.0× 267 0.9× 278 0.9× 96 3.1k
John G. Gambertoglio United States 31 565 0.7× 648 0.9× 572 1.8× 379 1.2× 320 1.1× 91 2.4k
Ulrika S. H. Simonsson Sweden 29 1.0k 1.2× 544 0.8× 619 1.9× 368 1.2× 459 1.6× 114 2.6k
Deborah M. Campoli-Richards United States 20 375 0.5× 655 0.9× 794 2.4× 163 0.5× 492 1.7× 22 2.7k
Scott Penzak United States 31 1.0k 1.2× 605 0.8× 350 1.1× 325 1.1× 469 1.6× 99 3.1k
Vincent Jullien France 31 1.1k 1.4× 736 1.0× 562 1.7× 744 2.4× 279 1.0× 125 3.3k
Kazuaki Matsumoto Japan 24 1.3k 1.5× 692 1.0× 1.0k 3.2× 140 0.5× 389 1.3× 188 2.6k

Countries citing papers authored by Richard D. Leff

Since Specialization
Citations

This map shows the geographic impact of Richard D. Leff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Leff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Leff more than expected).

Fields of papers citing papers by Richard D. Leff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Leff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Leff. The network helps show where Richard D. Leff may publish in the future.

Co-authorship network of co-authors of Richard D. Leff

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Leff. A scholar is included among the top collaborators of Richard D. Leff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Leff. Richard D. Leff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gerber, David E., Muhammad Shaalan Beg, Farjana Fattah, et al.. (2018). Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis. British Journal of Cancer. 119(8). 928–936. 67 indexed citations
3.
Srivastava, Shashikant, Carleton M. Sherman, Claudia Meek, Richard D. Leff, & Tawanda Gumbo. (2011). Pharmacokinetic Mismatch Does Not Lead to Emergence of Isoniazid- or Rifampin-Resistant Mycobacterium tuberculosis but to Better Antimicrobial Effect: a New Paradigm for Antituberculosis Drug Scheduling. Antimicrobial Agents and Chemotherapy. 55(11). 5085–5089. 37 indexed citations
4.
Srivastava, Shashikant, Jotam G. Pasipanodya, Claudia Meek, Richard D. Leff, & Tawanda Gumbo. (2011). Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability. The Journal of Infectious Diseases. 204(12). 1951–1959. 206 indexed citations
5.
Hall, Ronald G., Richard D. Leff, & Tawanda Gumbo. (2009). Treatment of Active Pulmonary Tuberculosis in Adults: Current Standards and Recent Advances. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(12). 1468–1481. 60 indexed citations
6.
Dowling, Thomas C., John E. Murphy, James S. Kalus, et al.. (2009). Recommended Education for Pharmacists as Competitive Clinical Scientists. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(2). 236–244. 26 indexed citations
7.
Blouin, Robert A., Richard F. Bergstrom, Vicki L. Ellingrod, et al.. (2007). Report of the AACP Educating Clinical Scientists Task Force. American Journal of Pharmaceutical Education. 71. S05–S05.
8.
9.
Leff, Richard D., et al.. (2005). New Concepts to Improve Health Outcomes for Patients With Chronic Obstructive Pulmonary Disease. Journal of Managed Care Pharmacy. 11(6 Supp A). 1–22. 1 indexed citations
10.
Leff, Richard D.. (2005). COPD Clinical Significance of Early Diagnosis. Journal of Managed Care Pharmacy. 11(6 Supp A). S8–S11. 3 indexed citations
11.
Lloyd, Thomas R., Benjamin E. Victorica, Vincent R. Zales, et al.. (2001). Iodixanol Pharmacokinetics in Children. Pediatric Cardiology. 22(3). 223–227. 7 indexed citations
12.
Erenberg, Allen, et al.. (2000). Caffeine Citrate for the Treatment of Apnea of Prematurity: A Double‐Blind, Placebo‐Controlled Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(6). 644–652. 105 indexed citations
13.
14.
Weatherstone, Kathleen B., et al.. (1993). Safety and Efficacy of a Topical Anesthetic for Neonatal Circumcision. PEDIATRICS. 92(5). 710–714. 32 indexed citations
15.
Thompson, Suzanne, et al.. (1991). Influence of infusion pumps on the pharmacologic response to nitroprusside. Critical Care Medicine. 19(1). 98–101. 20 indexed citations
16.
Roberts, Robert J. & Richard D. Leff. (1989). Influence of absorbable and nonabsorbable lipids and lipidlike substances on drug bioavailability. Clinical Pharmacology & Therapeutics. 45(3). 299–304. 24 indexed citations
17.
Schneider, Philip J., et al.. (1989). Decreased flow accuracy from volumetric infusion pumps. Critical Care Medicine. 17(9). 926–928. 10 indexed citations
18.
Leff, Richard D., et al.. (1988). Influence of Physical Characteristics of Intravenous Systemson Drug Delivery. Developmental Pharmacology and Therapeutics. 11(4). 189–195. 7 indexed citations
19.
Erenberg, Allen, et al.. (1988). Flow rate variability from electronic infusion devices. Critical Care Medicine. 16(9). 888–891. 24 indexed citations
20.
Leff, Richard D. & Robert J. Roberts. (1981). Methods for intravenous drug administration in the pediatric patient. The Journal of Pediatrics. 98(4). 631–635. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher J. Destache Breakdown of academic impact, for papers by Joost Wauters Breakdown of academic impact, for papers by Alison H. Thomson Breakdown of academic impact, for papers by B. Joseph Guglielmo Breakdown of academic impact, for papers by John G. Gambertoglio Breakdown of academic impact, for papers by Ulrika S. H. Simonsson Breakdown of academic impact, for papers by Deborah M. Campoli-Richards Breakdown of academic impact, for papers by Scott Penzak Breakdown of academic impact, for papers by Vincent Jullien Breakdown of academic impact, for papers by Kazuaki Matsumoto
Rankless by CCL
2026